Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-12-01

Clinical Trial Update: EUS-guided Ethanol-lipiodol Ablation of Pancreatic Neuroendocrine Tumor: a Prospective Study [NA]

View source ↗

Summary

An update on a prospective study evaluating endoscopic ultrasound-guided ethanol-lipiodol ablation for pancreatic neuroendocrine tumors to assess feasibility, e…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ethanol-lipiodol (ethanol-lipiodol)

Snippet

Sponsor: Asan Medical Center | Conditions: Efficacy, Safety | NA | Status: UNKNOWN